Foyston Gordon & Payne Inc Decreases Position in Kenvue Inc. (NYSE:KVUE)

Foyston Gordon & Payne Inc lessened its stake in Kenvue Inc. (NYSE:KVUE) by 63.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 62,724 shares of the company’s stock after selling 107,481 shares during the quarter. Foyston Gordon & Payne Inc’s holdings in Kenvue were worth $1,339,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of KVUE. Handelsbanken Fonder AB lifted its position in shares of Kenvue by 2.9% during the 4th quarter. Handelsbanken Fonder AB now owns 742,184 shares of the company’s stock valued at $15,846,000 after buying an additional 21,222 shares during the last quarter. Alberta Investment Management Corp raised its stake in Kenvue by 23.2% in the 4th quarter. Alberta Investment Management Corp now owns 582,895 shares of the company’s stock valued at $12,445,000 after acquiring an additional 109,700 shares during the period. Longbow Finance SA lifted its holdings in Kenvue by 5.0% during the fourth quarter. Longbow Finance SA now owns 280,568 shares of the company’s stock valued at $5,990,000 after purchasing an additional 13,287 shares during the last quarter. Steward Partners Investment Advisory LLC boosted its position in Kenvue by 143.1% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 47,938 shares of the company’s stock worth $1,023,000 after purchasing an additional 28,216 shares during the period. Finally, CORDA Investment Management LLC. increased its stake in shares of Kenvue by 1.4% in the fourth quarter. CORDA Investment Management LLC. now owns 1,253,096 shares of the company’s stock worth $26,754,000 after purchasing an additional 17,466 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently commented on KVUE. UBS Group raised their price objective on shares of Kenvue from $24.00 to $25.00 and gave the stock a “neutral” rating in a report on Friday. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $24.00 price target on shares of Kenvue in a report on Monday, February 3rd. Canaccord Genuity Group boosted their price objective on Kenvue from $24.00 to $29.00 and gave the company a “buy” rating in a research note on Wednesday, March 5th. Evercore ISI assumed coverage on Kenvue in a report on Monday, March 24th. They set an “in-line” rating and a $25.00 target price for the company. Finally, Redburn Atlantic started coverage on shares of Kenvue in a report on Thursday, April 10th. They issued a “neutral” rating and a $23.50 price target on the stock. Seven investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $25.25.

Kenvue Price Performance

KVUE opened at $24.47 on Friday. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $46.95 billion, a P/E ratio of 46.17, a PEG ratio of 2.62 and a beta of 1.02. The stock has a 50-day moving average price of $23.13 and a 200-day moving average price of $22.56. Kenvue Inc. has a 12-month low of $17.67 and a 12-month high of $25.17.

Kenvue (NYSE:KVUE) last issued its earnings results on Thursday, May 8th. The company reported $0.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.01. The business had revenue of $3.74 billion during the quarter, compared to analyst estimates of $3.69 billion. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. Kenvue’s revenue for the quarter was down 3.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.28 earnings per share. Equities analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 28th. Shareholders of record on Wednesday, May 14th will be given a dividend of $0.205 per share. The ex-dividend date is Wednesday, May 14th. This represents a $0.82 annualized dividend and a yield of 3.35%. Kenvue’s payout ratio is 154.72%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.